Eric o. Long - Nanotechnology

Author Information

Eric O. Long is affiliated with the Molecular and Cellular Immunology Section at the National Institute of Allergy and Infectious Diseases, National Institutes of Health, located in Rockville, MD 20852. His research primarily revolves around immunology, with a specific focus on the interactions between different immune cells and pathogens.

Research Contributions

Eric O. Long has made significant contributions to the field of immunology. His research has provided insights into the role of T cells in discriminating between groups C1 and C2 HLA-C, the dominance and expansion of Plasmodium falciparum-specific IgM B cells in children with malaria, and the characteristics of bone marrow-derived dendritic cell cultures from RAG−/− mice. Additionally, his work on NK cells in various contexts, including chronic active EBV and malaria exposure, has been influential. He has also contributed to understanding the effectiveness of adoptive T cell therapy targeting mutant KRAS-G12D and has explored CARs for NK cell cancer immunotherapy.

Aliases

Eric O. Long is known by several aliases in the scientific community, including Eric Long, E. O. Long, E. O Long, Eric o. Long, Eric O. Long, E O Long, and E Long.

Publication and Citation Metrics

Publication Year	Title	DOI
2021	T cells discriminate between groups C1 and C2 HLA-C	10.1101/2021.11.11.468262
2021	Plasmodium falciparum–specific IgM B cells dominate in children, expand with malaria, and produce functional IgM	10.1084/jem.20200901
2020	Bone Marrow–Derived Dendritic Cell Cultures from RAG−/− Mice Include IFN-γ–Producing NK Cells	10.4049/immunohorizons.2000011
2020	Plasmodium falciparum-specific IgM B cells dominate in children, expand with malaria and produce parasite inhibitory IgM	10.1101/2020.04.12.030049
2020	High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D	10.1073/pnas.1921964117
2020	Correction	10.1016/j.jacc.2019.11.020
2020	Patients with NK cell chronic active EBV have immature NK cells and hyperactivation of PI3K/Akt/mTOR and STAT1 pathways.	10.1093/infdis/jiaa232
2020	PD-1 Expression on NK Cells in Malaria-Exposed Individuals Is Associated with Diminished Natural Cytotoxicity and Enhanced Antibody-Dependent Cellular Cytotoxicity	10.1128/IAI.00711-19
2019	Inhibition-Resistant CARs for NK Cell Cancer Immunotherapy.	10.1016/j.it.2019.10.004
2019	HLA-C-restricted presentation of a conserved bacterial epitope to an innate NK cell receptor	10.1101/550889